This Cellular Analysis Optofluidic System is designed to streamline antibody discovery workflows. Featuring negative pressure fluidics and advanced optofluidic technology, this state-of-the-art system enables precise sample handling and high-throughput multiplexed assays for accelerated antibody screening and development. Leveraging the Opto B Discovery workflows, it significantly reduces discovery timelines to just 1–2 weeks, helping researchers identify potent antibody sequences efficiently.
Product Features
- Negative pressure fluidics for accurate and gentle sample manipulation
- Optimized for antibody discovery and screening applications
- Supports high-throughput analysis with multiplexed detection
- Enables function-first assays targeting rare and high-affinity antibodies
- Customized assays for soluble and membrane-bound targets
- Multi-assay capability screening tens of thousands of B cells simultaneously
- Robust design for reliable performance in demanding laboratory environments
- Compact and user-friendly system requiring minimal laboratory space
- High-quality imaging with up to five fluorescence channels plus brightfield
- Free-standing unit dimensions: 46" W x 34" D x 71.5" H; Weight approx. 1,260 lb
- Operates optimally at 64–79°F with 20–60% humidity
Benefits
- Enhances antibody screening efficiency with precise fluid control
- Enables multiplexed assays for comprehensive antibody characterization
- Targets rare antibodies often missed by conventional methods
- Increases antibody hit rates up to 10-fold and sequence diversity up to 50-fold
- Reduces sample loss and contamination risks
- Improves workflow automation and reproducibility
- Streamlines screening and recovery of lead candidates in a single-run process
- Significantly shortens antibody discovery timelines from months to days
Why Choose This Cellular Analysis Optofluidic System?
This system offers unmatched precision and flexibility for antibody discovery, helping researchers accelerate development and achieve reliable results with ease. Specifically designed for research and development, it is not intended for diagnostic use but focuses on advancing the frontiers of antibody research through innovative technology and integrated workflows.
